Insights

How Listed Entities are Falling Foul of the New ESS Regime

Table of Contents

stock exchange, pay, business-1222518.jpg

ASX entities who rely on Listing Rule exemptions to issue securities under their employee incentive schemes, and who also rely on the streamlined disclosure requirements in Division 1A of Part 7.12 of the Corporations Act may be inadvertently in breach of the provisions of the new employee share scheme regime (ESS Regime). Falling foul of the ESS Regime may result in a listed entity committing various breaches of, or offences under, the Corporations Act, and can lead to personal liability for certain persons, including directors.

One of the requirements of the new ESS Regime is that if monetary consideration is payable by a participant for the grant of securities (whether at the time of grant, or on exercise) then a listed entity must comply with the issue cap. Unless a higher cap is specified in the entity’s constitution, the default issue cap for listed entities is 5% of total shares on issue as at the date the offer is made (Issue Cap).  This means that if a listed entity’s constitution does not specify an issue cap at all (which is often the case), and the entity wishes to benefit from the regulatory relief provided by the new ESS Regime, then it must comply with the default 5% Issue Cap. If the Issue Cap is breached, then regulatory relief from the standard compliance and disclosure obligations under Parts 6D.2 and 6D.3 or 7.9 of the Corporations Act is revoked. 

The Issue Cap will not fit well for with listed entities, even if members approval is granted in accordance with Listing Rule 7.2 Exemption 13(b). That exemption excludes from the restrictions in Listing Rules 7.1 and 7.1A an issue of securities under an employee incentive scheme, if within 3 years before the issue date, the ordinary members have approved the issue under such a scheme. To qualify under that exemption requires, amongst other things, that the relevant notice of meeting specifies the maximum number of securities proposed to be issued under the employee share scheme in the relevant period. Under that exemption, the total amount that can be approved by members may therefore be greater than the 5% default Issue Cap.

Thus, some ASX entities may find themselves in the position that whilst their members have approved the issue of securities under an employee incentive scheme in accordance with the Listing Rules, that the company nonetheless runs afoul of the new ESS Regime.  This is simply by virtue of the fact that even if members have approved a maximum number of securities in accordance with the Listing Rules, if the actual number of securities issued exceeds either the default 5% Issue Cap (or any higher issue cap set out in the company’s constitution) then the entity may have breached the requirements of the ESS Regime (and regulatory relief is revoked). 

Compounding this untenable situation for many ASX companies is that member approval under the relevant Listing Rule exemption was obtained before the New Regime came into effect late 2022. Those unlucky companies may find themselves in the situation that they have already exceeded the Issue Cap and are wondering what they can do to make themselves compliant not only with the Corporations Act, but also the Listing Rules. 

Our experienced corporate lawyers are familiar with this issue and know how to deal with it. With the time for annual meetings fast approaching, now is the time to touch base with us to see how we can help you.

If you are an interested in reading more about the ESS regime, ESOPs generally, or tax implications of ESOPs for unlisted entities then check out our articles: The Dangers of Out-Of-Date ESOPs and Embrace Change: Why You Need to Update Your Australian Employee Share Option Plan.

Author

  • Kelly is also an experienced regulatory compliance lawyer. She assists clients to navigate through the minefield of regulatory investigations, including those initiated by the Australian Competition and Consumer Commission. She advises on and responds to regulatory notices, advocates on behalf of clients and provides in-house corporate compliance training, policies, and procedures.

    View all posts

More Posts

ESOPs and Overseas Employees: Why Multi-National Share Plans Become Expensive for Australian Companies

For Australian companies, an ESOP, employee share scheme or share plan can be a great way to attract and retain staff by giving them a future stake in the business. But the position becomes much more complicated when the company wants to offer options to employees based overseas. What looks like a simple extension of an Australian employee share option plan can quickly become an expensive and time-consuming compliance exercise. Once you move into the world of multi-national share plans or global share plans, you are no longer just dealing

How Convertible Notes, SAFEs and Warrants Work Together in the Capital Raising Stack

In Australia, across early and growth-stage funding, convertible notes, SAFEs and warrants are rarely used in isolation. They are typically layered over time – sometimes deliberately, sometimes opportunistically, as founders raise capital in stages before a larger priced equity round. Having examined each instrument individually in the earlier articles in this series, it is equally important to understand how each instrument operates together. The practical consequences of capital raising often emerge not from the terms of a single instrument, but from the way multiple instruments interact within a company’s capital

right, advocacy, lex-4703926.jpg

Startup Warrants Explained: Key Terms, Dilution and How Warrants Work in Startup Financing

In startup and venture financing, a startup warrant is a right, but not an obligation, to purchase shares in a company at a predetermined price (known as the strike price) within a specified period. Warrants are often issued alongside other investment instruments to provide additional upside to investors or strategic partners. They are commonly used in venture debt arrangements, strategic investment transactions and advisory agreements to help align incentives between investors and the company. Warrants are a familiar feature of startup and scaleup financing, but they are often less well

Understanding Simple Agreements for Future Equity

Simple Agreement for Future Equity (SAFE) is a financing instrument used in startup capital raising that gives an investor the right to receive shares in a future equity round if specified events occur. SAFEs allow startups to raise capital quickly while deferring valuation and share issuance until a later funding round. SAFEs have become a common feature of early-stage capital raising in Australia, particularly at pre-seed and seed stage. They are often described as a faster, simpler alternative to convertible notes, and are designed to help companies raise capital without